feed,title,long_url,short_url
MedRxiv,SARS-CoV-2 seroconversion in response to infection and vaccination: A time series local study in Brazil,https://medrxiv.org/cgi/content/short/2022.03.10.22271805v1?rss=1,https://bit.ly/3tKTJMA
MedRxiv,"Current epidemiological situation of COVID-19 in the Republic of Belarus: characteristics of the epidemic process, sanitary and anti-epidemic measures",https://medrxiv.org/cgi/content/short/2022.03.10.22271815v1?rss=1,https://bit.ly/3KCuKlo
MedRxiv,Seroneutralization of Omicron BA.1 and BA.2 in patients receiving anti-SARS-CoV-2 monoclonal antibodies,https://medrxiv.org/cgi/content/short/2022.03.09.22272066v1?rss=1,https://bit.ly/3tVbR6q
MedRxiv,Blood group O and post-COVID-19 syndrome,https://medrxiv.org/cgi/content/short/2022.03.10.22272197v1?rss=1,https://bit.ly/3tLcz64
MedRxiv,Evidence for SARS-CoV-2 Delta and Omicron co-infections and recombination,https://medrxiv.org/cgi/content/short/2022.03.09.22272113v1?rss=1,https://bit.ly/3pZPnjo
MedRxiv,Prevention of SARS-CoV-2 airborne transmission in a workplace based on CO2 sensor network,https://medrxiv.org/cgi/content/short/2022.03.04.22271934v1?rss=1,https://bit.ly/3CH5gAv
